Consult the medical resource doctors trust

UpToDate is one of the most respected evidence-based medical information resources in the world, used by over 400,000 doctors and thousands of patients to find answers to medical questions.

  • Content written by a faculty of over 4,000 physicians from leading medical institutions
  • Unbiased: free of advertising or pharmaceutical funding
  • Evidence-based treatment recommendations
  • Continuously updated to incorporate new medical findings

Related articles

Preview Available
(subscription required for full access)

Overview of acquired peripheral neuropathies in children

INTRODUCTION

Peripheral neuropathy is a disorder of the peripheral nerves of any cause. It typically is characterized by symmetric distal sensory loss, dysesthesias such as burning, or weakness. Most peripheral nerve disorders in children are hereditary (figure 1). However, many systemic illnesses, drugs, and toxins affect the peripheral nervous system (table 1).

An overview of acquired peripheral neuropathies is presented here. Hereditary peripheral neuropathies and specific disorders that affect the peripheral nerves are discussed separately. (See appropriate topic reviews).

CLINICAL FEATURES

Most peripheral nerve disorders have a gradual and slowly progressive course. Acute presentation may occur with toxic exposure or inflammatory conditions.

Most peripheral neuropathies show bilateral, symmetric, predominantly distal involvement. The injury is related directly to axon length; thus, longer axons are affected first, resulting in symptoms that typically have an earlier presentation and are more prominent in the lower extremities. Most have combined sensory and motor involvement. However, some disorders have only motor or sensory abnormalities.

The most common motor symptom is weakness. It may present as clumsiness, difficulty with running or climbing stairs, or impaired fine motor skills such as writing, buttoning clothes, or tying shoes. Sensory symptoms may include numbness, dysesthesias such as burning pain, or ataxia.

» To continue reading this article you need to login or subscribe.

Ready to join over 400,000 satisfied users? Subscribe to read this article and others like it.
Last literature review version 18.2: May 2010
This topic last updated: January 13, 2010
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use (click here) ©2010 UpToDate, Inc.
References
Top
  1. Belman, AL, Iyer, M, Coyle, PK, Dattwyler, R. Neurologic manifestations in children with North American Lyme disease. Neurology 1993; 43:2609.
  2. Blanco, SB, Segura, EL, Cura, EN, Chuit, R. Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in north-western Argentina. Trop Med Int Health 2000; 5:293.
  3. Genovese, O, Ballario, C, Storino, R, Segura, E. Clinical manifestations of peripheral nervous system involvement in human chronic Chagas disease. Arq Neuropsiquiatr 1996; 54:190.
  4. Sica, RE, Gonzalez Cappa, SM, Sanz, OP, Mirkin G. Peripheral nervous system involvement in human and experimental chronic American trypanosomiasis. Bull Soc Pathol Exot 1995; 88:156..
  5. Logina, I, Donaghy, M. Diphtheritic polyneuropathy: a clinical study and comparison with Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1999; 67:433.
  6. Krebs, JW, Mandel, EJ, Swerdlow, DL, Rupprecht, CE. J Am Vet Med Assoc 2005; 227:1912.
  7. Chopra, JS, Banerjee, AK, Murthy, JM, Pal, SR. Paralytic rabies. A clinico-pathological study. Brain 1980; 103:789.
  8. Tangchai, P, Vejjajiva, A. Pathology of the peripheral nervous system in human rabies. A study of nine autopsy cases. Brain 1971; 94:299.
  9. Hattwick, MA. Reactions to rabies. N Engl J Med 1972; 287:1204.
  10. Wilder-Smith, A, Wilder-Smith, E. Electrical evaluation of peripheral autonomic function in leprosy patients: Leprosy contacts and controls. Int J Lepr Other Mycobact Dis 1996; 64:433.
  11. Sladky, JT. Neuropathy in childhood. Semin Neurol 1987; 7:67.
  12. Nevo, Y, Pestronk, A, Kornberg, AJ, et al. Childhood chronic demyelinating neuropathies: Clinical course and long term follow-up. Neurology 1996; 47:98.
  13. Peyronnard, JM, Charron, L, Beaudet, F, et al. Vasculitic neuropathy in rheumatoid disease and Sjogren syndrome. Neurology 1982; 32:839.
  14. McCombe, PA, Klestov, AC, Tannenberg, AE, Chalk, JB. Sensorimotor peripheral neuropathy in rheumatoid arthritis. Clin Exp Neurol 1991; 28:146.
  15. Omdal, R, Loseth, S, Torbergsen, T, et al. Peripheral neuropathy in systemic lupus erythematosus - a longitudinal study. Acta Neurol Scand 2001; 103:386.
  16. Huynh, C, Ho, SL, Fong, KY, Cheung, RT. Peripheral neuropathy in systemic lupus erythematosus. J Clin Neurophysiol 1999; 16:164.
  17. Steinlin, MI, Blaser, SI, Gilday, DL, Eddy, AA. Neurologic manifestations of pediatric systemic lupus erythematosus. Pediatr Neurol 1995; 13:191.
  18. Parikh, S, Swaiman, KF, Kim, Y. Neurologic characteristics of childhood lupus erythematosus. Pediatr Neurol 1995; 13:198.
  19. McCombe, PA, McLeod, JG, Pollard, JD, et al. Peripheral sensorimotor and autonomic neuropathy associated with systemic lupus erythematosus. Clinical, pathological and immunological features. Brain 1987; 110 ( Pt 2):533.
  20. Lossos, A, River, Y, Eliakim, A, et al. Neurologic aspects of inflammatory bowel disease. Neurology 1995; 45:416.
  21. Nemni, R, Fazio, R, Corbo, M, Sessa, M. Peripheral neuropathy associated with Crohn's disease. Neurology 1987; 37:1414.
  22. Duval, L, Lucidarme, D, Delalande, I, Creuzy, C. [Sensorimotor polyneuropathy in a flare-up of Crohn disease]. Rev Med Interne 1997; 18:230.
  23. Humbert, P, Monnier, G, Billerey, C, Birgen, C. Polyneuropathy: an unusual extraintestinal manifestation of Crohn's disease. Acta Neurol Scand 1989; 80:301.
  24. Neundorfer, B. [Neurologic concomitant diseases in Crohn disease]. Fortschr Neurol Psychiatr 1992; 60:481.
  25. Duffy, LF, Daum, F, Fisher, SE, Selman, J. Peripheral neuropathy in Crohn's disease patients treated with metronidazole. Gastroenterology 1985; 88:681.
  26. Ohkoshi, N, Migusama, H, Oguni, E, Shoji, S. Sural nerve biopsy in vasculitic neuropathies: Morphometric analysis of the caliber of involved vessels. J Med 1996; 27:153.
  27. Tervaert, JW, Kallenberg, C. Neurologic manifestations of systemic vasculitides. Rheum Dis Clin North Am 1993; 19:913.
  28. Moore, PM. Neurologic manifestations of vasculitis: Update on immunopathogenic mechanisms and clinical features. Ann Neurol 1995; 37(Suppl 1):S131.
  29. Bulun, A, Topaloglu, R, Duzova, A, et al. Ataxia and peripheral neuropathy: rare manifestations in Henoch-Schonlein purpura. Pediatr Nephrol 2001; 16:1139.
  30. Guillevin, L, Cohen, P, Gayraud, M, et al. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999; 78:26.
  31. Farooki, ZQ, Brough, AJ, Green, EW. Necrotizing arteritis. Am J Dis Child 1974; 128:837.
  32. Sehgal, M, Swanson, JW, DeRemee, Ra, et al. Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc 1995; 70:337.
  33. Solans, R, Bosch, JA, Perez-Bocanegra, C, et al. Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients. Rheumatology (Oxford) 2001; 40:763.
  34. Nishino, H, Rubino, FA, DeRemee, RA, Swanson, JW. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 1993; 33:4.
  35. de Groot, K, Schmidt, DK, Arlt, AC, Gross, WL. Standardized neurologic evaluations of 128 patients with Wegener granulomatosis. Arch Neurol 2001; 58:1215.
  36. Rottem, M, Fauci, AS, Hallahan, CW, et al. Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr 1993; 122:26.
  37. Alexander, E. Central nervous system disease in Sjogren's syndrome. New insights into immunopathogenesis. Rheum Dis Clin North Am 1992; 18:637.
  38. Molina, RM, Provost, TT, Alexander, EL. Peripheral inflammatory vascular disease in Sjorgren's syndrome, association with nervous system complications. Arthritis Rheum 1985; 28:1341.
  39. Anaya, JM Ogawa, N, Talal, N. Sjogren's syndrome in childhood. J Rheumatol 1995; 22:1152.
  40. Kaplan, JG, Rosenberg, R, Reinitz, E, Buchbinder, S. Invited review: peripheral neuropathy in Sjogren's syndrome. Muscle Nerve 1990; 13:570.
  41. Mochizuki, H, Kamakura, K, Masaki, T, Hirata, A. Motor dominant neuropathy in Sjogren's syndrome: report of two cases. Intern Med 2002; 41:142.
  42. Mellgren, SI, Conn, DL, Stevens, JC, et al. Peripheral neuropathy in primary Sjögren's syndrome. Neurology 1989; 39:390.
  43. Grant, IA, Hunder, GG, Homburger, HA, Dyck, PJ. Peripheral neuropathy associated with sicca complex. Neurology 1997; 48:855.
  44. Fraser, CL, Arieff, AI. Nervous system complications in uremia. Ann Intern Med 1988; 109:143.
  45. Makkar, RK, Kochar, DK. Somatosensory evoked potentials (SSEPs); sensory nerve conduction velocity (SNCV) and motor nerve conduction velocity (MNCV) in chronic renal failure. Electromyogr Clin Neurophysiol 1994; 34:295.
  46. Menegaux, F, Keeffe, EB, Andrews, BT, Egawa, H. Neurological complications of liver transplantation in adult versus pediatric patients. Transplantation 1994; 58:447.
  47. Amato, AA, Barohn, RJ, Sahenk, A, et al. Polyneuropathy complicating bone marrow and solid organ transplantation. Neurology 1993; 43:1513.
  48. Adams, C, August, CS, Maguire, H, Sladky, JT. Neuromuscular complications of bone marrow transplantation. Pediatr Neurol 1995; 12:58.
  49. Leijten, FS, De Weerd, AW, Poortvliet, DC, et al. Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intensive Care Med 1996; 22:856.
  50. Petersen, B, Schneider, C, Strassburg, HM, Schrod, L. Critical illness neuropathy in pediatric intensive care patients. Pediatr Neurol 1999; 21:749.
  51. Wijdicks, EF, Litchy, WJ, Harrison, BA, Gracey, DR. The clinical spectrum of critical illness polyneuropathy. Mayo Clin Proc 1994; 69:955.
  52. Gooch, J, Succhyta, M, Balbierz, J, et al. Prolonged paralysis after treatment with neuromuscular junction blocking agents. Crit Care Med 1991; 19:1125.
  53. Watling, SM, Dasta, JF. Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: A review of the literature. Crit Care Med 1994; 22:884.
  54. Verrotti, A, Giuva, PT, Morgese, G, Chiarelli, F. New trends in the etiopathogenesis of diabetic peripheral neuropathy. J Child Neurol 2001; 16:389.
  55. Verrotti, A, Chiarelli, F, Blasetti, A, Morgese, G. Autonomic neuropathy in diabetic children. J Paediatr Child Health 1995; 31:545.
  56. Solders, G, Thalme, B, Aguirre-Aquino, M, et al. Nerve conduction and autonomic nerve function in diabetic children. A 10-year follow-up study. Acta Paediatr 1997; 86:361.
  57. Donaghue, KC, Fung, AT, Fairchild, JM, et al. Prospective assessment of autonomic and peripheral nerve function in adolescents with diabetes. Diabet Med 1996; 13:65.
  58. Hyllienmark, L, Brismar, T, Ludvigsson, J. Subclinical nerve dysfunction in children and adolescents with IDDM. Diabetologia 1995; 38:685.
  59. Khedr, EM, El Toony, LF, Tarkhan, MN, Abdella, G. Peripheral and central nervous system alterations in hypothyroidism: electrophysiological findings. Neuropsychobiology 2000; 41:88.
  60. Zelnik, N, Pacht, A, Obeid, R, Lerner, A. Range of neurologic disorders in patients with celiac disease. Pediatrics 2004; 113:1672.
  61. Ruggieri, M, Incorpora, G, Polizzi, A, et al. Low prevalence of neurologic and psychiatric manifestations in children with gluten sensitivity. J Pediatr 2008; 152:244.
  62. Kaplan, JG, Pack, D, et al. Distal axonopathy associated with chronic gluten enteropathy. A treatable disorder. Neurology 1988; 38:642.
  63. Kurczynski, TW. Remote effects of malignancy on the nervous system in children. Dev Med Child Neurol 1980; 22:205.
  64. Rowland, LP, Schneck, SA. Neuromuscular disorders associated with malignant neoplastic disease. J Chronic Dis 1963; 16:777.
  65. McCloud, JG, Walsh, JC. Peripheral neuropathy associated with lymphomas and other reticuloses. In: Peripheral Neuropathy, Vol 2, 2nd ed, Dyck, PJ, Thomas, PK, Lambert, EH, Bunge, R, (Eds) WB Saunders, Philadelphia 1984. p.2192.
  66. Guggenheim, MA, Ringel, SP, Silverman, A, Grabert, BE. Progressive neuromuscular disease in children with chronic cholestasis and vitamin E deficiency: diagnosis and treatment with alpha tocopherol. J Pediatr 1982; 100:51.
  67. Werlin, SL, Harb, JM, Swick, G, et al. Neuromuscular dysfunction and ultrastructural pathology in children with chronic cholestasis and vitamin E deficiency. Ann Neurol 1983; 13:291.
  68. Rosenblum, JL, Keating, JP, Prensky, AL, et al. A progressive neurologic syndrome in children with chronic liver disease. N Engl J Med 1981; 304:503.
  69. Grattan-Smith, PJ, Wilcken, B, Procopis, PJ, et al. The neurological syndrome infantile cobalamin deficiency: Development regression and involuntary movements. Mov Disord 1997; 12:39.
  70. Renault, F, Verstichel, P, Ploussard, JP, Costil, J. Neuropathy in two cobalamin-deficient breast-fed infants of vegetarian mothers. Muscle Nerve 1999; 22:252.
  71. Mackenzie, IL, Donaldson, RM Jr, Trier, JS, Mathan, VI. Ileal mucosa in familial selective vitamin B 12 malabsorption. N Engl J Med 1972; 286:1021.
  72. Graham, SM, Arvela, OM, Wise, GA. Long-term neurologic consequences of nutritional vitamin B12 deficiency in infants. J Pediatr 1992; 121:710.
  73. Matthews, DM, Linnell, JC. Cobalamin deficiency and related disorders in infancy and childhood. Eur J Pediatr 1982; 138:6.
  74. Lindenbaum, J, Healton, EB, Savage, DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988; 318:1720.
  75. Cochrane, WA, Collins-Williams, C, Donohue, WL. Superior hemorrhagic polioencephalitis (Wernicke's disease) occurring in an infant-probably due to thiamine deficiency from use of a soya bean product. Pediatrics 1961; 28:771.
  76. Snodgrass, SR. Vitamin neurotoxicity. Mol Neurobiol 1992; 6:41.
  77. Dellon, AL, Dellon, ES, Tassler, PL, Ellefson, RD. Experimental model of pyridoxine (B6) deficiency-induced neuropathy. Ann Plast Surg 2001; 47:153.
  78. Snider, DE Jr. Pyridoxine supplementation during isoniazid therapy. Tubercle 1980; 61:191.
  79. Schaumburg, H, Kaplan, J, Windebank, A, et al. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med 1983; 309:445.
  80. Albin, RL, Albers, JW, Greenberg, HS, et al. Acute sensory neuropathy-neuronopathy from pyridoxine overdose. Neurology 1987; 37:1729.
  81. Windebank, AJ, Low, PA, Blexrud, MD, Schmelzer, JD. Pyridoxine neuropathy in rats: specific degeneration of sensory axons. Neurology 1985; 35:1617.
  82. Santoro, L, Ragno, M, Nucciotti, R, et al. Pyridoxine neuropathy. A four year electrophysiological and clinical follow-up of a severe case. Acta Neurol (Napoli) 1991; 13:13.
  83. Wilson, JA. Vitamin deficiency and excess. In: Harrison's principles of internal medicine Harrison's Principles of Internal Medicine, 14th edition, Fauci, AS, Braunwald, E, Isselbacher, K, (Eds) et al, McGraw-Hill, New York 1998. p.481.
  84. Bademosi, O, Osuntokun, BO. Diseases of peripheral nerves as seen in the Nigerian African. Afr J Med Med Sci 1981; 10:33.
  85. Hilkens, PH, ven den, Bent MJ. Chemotherapy-induced peripheral neuropathy. J Peripher Nerv Syst 1997; 2:350.
  86. Beinert, T, Masuhr, F, Mwela, E, Schweigert, M. Neuropathy under chemotherapy. Eur J Med Res 2000; 5:415.
  87. Pardo, CA, McArthur, JC, Griffin, JW. HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J Peripher Nerv Syst 2001; 6:21.
  88. Dalakas, MC. Peripheral neuropathy and antiretroviral drugs. J Peripher Nerv Syst 2001; 6:14.
  89. Snavely, SR, Hodges, GR. The neurotoxicity of antibacterial agents. Ann Intern Med 1984; 101:92.
  90. Mochizuki, Y, Suyehiro, Y, Tanizawa, A, Ohkubo, H. Peripheral neuropathy in children on long-term phenytoin therapy. Brain Dev 1981; 3:375.
  91. Eriksson, T, Bjorkman, S, Hoglund, P. Clinical pharmacology of thalidomide. Eur J Clin Pharmacol 2001; 57:365.
  92. Das, D, Chatterjee, A, Mandal, BK, et al. Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the world. Part 2. Concentrations in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy) of affected people. Analyst 1995; 120:917.
  93. Kersjes, MP, et al. An analysis of arsenic exposure referred to Blodget Regional Poison Center. Vet Hum Toxicol 1987; 29:75.
  94. Hall, AH. Chronic arsenic poisoning. Toxicol Lett 2002; 128:69.
  95. Behse, F, Carlson, F. Histologic and ultrastructure of alterations in neuropathy. Muscle Nerve 1978; 1:368.
  96. Letz, R, Gerr, F, Cragle, D, Green, RC. Residual neurologic deficits 30 years after occupational exposure to elemental mercury. Neurotoxicology 2000; 21:459.
  97. Galvan-Arzate, S, Santamaria, A. Thallium toxicity. Toxicol Lett 1998; 99:1.
  98. Thallium poisoning from eating contaminated cake--Iraq, 2008. MMWR Morb Mortal Wkly Rep 2008; 57:1015.
  99. Jenkins, RB, Toole, JF. Polyneuropathy following exposure to insecticides. Two cases of polyneuropathy with albuminocytologic dissociation in the spinal fluid following exposure to DDD and aldrin and DDT and endrin. Arch Intern Med 1964; 113:691.
  100. n-Hexane-related peripheral neuropathy among automotive technicians--California, 1999-2000. MMWR Morb Mortal Wkly Rep 2001; 50:1011.
  101. Kuwabara, S, Kai, MR, Nagase, H, Hattori, T. n-Hexane neuropathy caused by addictive inhalation: clinical and electrophysiological features. Eur Neurol 1999; 41:163.
  102. Korobkin, R, Asbury, AK, Summer, AJ, Nielsen, SL. Glue-sniffing neuropathy. Arch Neurol 1975; 32:158.
  103. Herskowitz, A, Ishii, N, Schaumburg, H. N-hexane neuropathy. A syndrome occurring as a result of industrial exposure. N Engl J Med 1971; 285:82.
Overview of acquired peripheral neuropathies in children